Kieren D. Marini

613 total citations
9 papers, 330 citations indexed

About

Kieren D. Marini is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kieren D. Marini has authored 9 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Kieren D. Marini's work include Epigenetics and DNA Methylation (4 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Kieren D. Marini is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Lung Cancer Research Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Kieren D. Marini collaborates with scholars based in Australia, United States and Spain. Kieren D. Marini's co-authors include D. Neil Watkins, Luciano G. Martelotto, Fernando J. Rossello, Jason E. Cain, W. Samantha N. Jayasekara, Ayumu Taguchi, Eunice Murage, Johannes F. Fahrmann, Edwin J. Ostrin and Mitzi Aguilar and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Kieren D. Marini

9 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kieren D. Marini Australia	8	229	118	80	42	42	9	330
Melanie Dujka United States	7	223 1.0×	122 1.0×	56 0.7×	21 0.5×	44 1.0×	12	344
Xian-Zi Yang China	8	225 1.0×	95 0.8×	95 1.2×	21 0.5×	23 0.5×	8	320
Kevin S. Quackenbush United States	12	228 1.0×	219 1.9×	112 1.4×	47 1.1×	71 1.7×	17	423
Justin Mastroianni Germany	8	237 1.0×	112 0.9×	127 1.6×	49 1.2×	27 0.6×	11	366
Federica Lorenzi United Kingdom	6	230 1.0×	192 1.6×	104 1.3×	31 0.7×	24 0.6×	8	372
Reham Helwa Egypt	9	210 0.9×	75 0.6×	99 1.2×	19 0.5×	49 1.2×	19	322
Yingke Zhou China	12	256 1.1×	154 1.3×	96 1.2×	19 0.5×	72 1.7×	17	366
Arianna Bellazzo Italy	8	253 1.1×	157 1.3×	128 1.6×	19 0.5×	30 0.7×	12	367
Xiao-Feng Sun Sweden	12	279 1.2×	110 0.9×	163 2.0×	52 1.2×	31 0.7×	19	392
Hiu Fung Yuen Singapore	8	256 1.1×	123 1.0×	86 1.1×	24 0.6×	52 1.2×	9	350

Countries citing papers authored by Kieren D. Marini

Since Specialization

Citations

This map shows the geographic impact of Kieren D. Marini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kieren D. Marini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kieren D. Marini more than expected).

Fields of papers citing papers by Kieren D. Marini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kieren D. Marini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kieren D. Marini. The network helps show where Kieren D. Marini may publish in the future.

Co-authorship network of co-authors of Kieren D. Marini

This figure shows the co-authorship network connecting the top 25 collaborators of Kieren D. Marini. A scholar is included among the top collaborators of Kieren D. Marini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kieren D. Marini. Kieren D. Marini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kostyrko, Kaja, Marta Román, Alex G. Lee, et al.. (2023). UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. Nature Communications. 14(1). 3966–3966. 19 indexed citations

Sayles, Leanne C., Amanda Koehne, Kieren D. Marini, et al.. (2019). Abstract 2880: Targeted drug therapies for osteosarcoma. Cancer Research. 79(13_Supplement). 2880–2880. 1 indexed citations

Márquez, César, Kaja Kostyrko, Amanda Koehne, et al.. (2019). Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma. Nature Medicine. 25(11). 1783–1795. 51 indexed citations

Tripathi, S. C., Johannes F. Fahrmann, Müge Çeliktaş, et al.. (2017). MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway. Cancer Research. 77(16). 4414–4425. 85 indexed citations

Muscat, Andrea, W. Samantha N. Jayasekara, Fernando J. Rossello, et al.. (2016). Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors. Clinical Cancer Research. 22(14). 3560–3570. 45 indexed citations

Leong, Tracy L., Kieren D. Marini, Fernando J. Rossello, et al.. (2014). Genomic Characterisation of Small Cell Lung Cancer Patient-Derived Xenografts Generated from Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Specimens. PLoS ONE. 9(9). e106862–e106862. 26 indexed citations

Rossello, Fernando J., Richard W. Tothill, Kara L. Britt, et al.. (2013). Next-Generation Sequence Analysis of Cancer Xenograft Models. PLoS ONE. 8(9). e74432–e74432. 24 indexed citations

Cain, Jason E., W. Samantha N. Jayasekara, Fernando J. Rossello, et al.. (2013). Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells. Sarcoma. 2013. 1–11. 27 indexed citations

Marini, Kieren D., et al.. (2011). Mechanisms of Hedgehog signalling in cancer. Growth Factors. 29(6). 221–234. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact